Reported 2 days ago
In its Q2 2025 investor letter, Sound Shore Management added Teva Pharmaceutical Industries Limited (NYSE:TEVA) to its portfolio, citing the company's ongoing growth strategy and resilience despite regulatory uncertainties in the healthcare sector. Notably, Teva's stock saw a 15.02% return in the month leading up to the letter and a 10.22% increase over the past year, highlighting its potential as a valuable investment amidst market fluctuations.
Source: YAHOO